Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2006; 12(47): 7561-7567
Published online Dec 21, 2006. doi: 10.3748/wjg.v12.i47.7561
Published online Dec 21, 2006. doi: 10.3748/wjg.v12.i47.7561
Lead author | Yr | n | Location of tumor thrombus | Treatment | Mortality within 1 mo (%) | Response rate (%) | Median survival time (mo) |
Yamada R et al[9] | 1983 | 9 | Vp4 | TACE | 55.5 | - | - |
Okazaki M et al[10] | 1991 | 48 | Vp2 | TACE | 6.5 | - | 4.3 |
56 | Vp3 | TACE | 8 | - | 4 | ||
59 | Vp4 | TACE | 5.6 | - | 3.8 | ||
Raoul JL et al[14] | 1994 | 27 | Vp3, 4 | 131I-labeled lipiodol | 0 | 40 | 6 |
Chung JW et al[12] | 1995 | 110 | Vp3, 4 | TACE | 2.7 | 28 | 6 |
Georgiades CS et al[13] | 2005 | 32 | Vp3, 4 | TACE | 0 | - | 9.5 |
- Citation: Minagawa M, Makuuchi M. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol 2006; 12(47): 7561-7567
- URL: https://www.wjgnet.com/1007-9327/full/v12/i47/7561.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i47.7561